Scarica l'app Stockscreener
3.69
2.79%
0.10
Dopo l'orario di chiusura:
3.76
0.07
+1.90%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$3.59
Aprire:
$3.58
Volume 24 ore:
175.25K
Relative Volume:
0.29
Capitalizzazione di mercato:
$233.55M
Reddito:
-
Utile/perdita netta:
$-45.08M
Rapporto P/E:
-5.0548
EPS:
-0.73
Flusso di cassa netto:
$-33.68M
1 W Prestazione:
+11.82%
1M Prestazione:
+69.27%
6M Prestazione:
+183.85%
1 anno Prestazione:
+73.24%
Intervallo 1D:
$3.50
$3.71
Intervallo di 1 settimana:
$3.30
$3.89
Portata 52W:
$0.726
$3.9035
Galectin Therapeutics Inc Stock (GALT) Company Profile
Nome
Galectin Therapeutics Inc
Settore
Industria
Telefono
678-620-3186
Indirizzo
4960 PEACHTREE INDUSTRIAL BOULEVARD, NORCROSS, GA
Confronta GALT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GALT
Galectin Therapeutics Inc
|
3.69 | 231.01M | 0 | -45.08M | -33.68M | -0.73 |
|
VRTX
Vertex Pharmaceuticals Inc
|
374.98 | 118.67B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.90 | 59.23B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
418.91 | 52.67B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
674.90 | 41.24B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.23 | 32.36B | 3.81B | -644.79M | -669.77M | -6.24 |
Galectin Therapeutics Inc Stock (GALT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-17 | Ripresa | H.C. Wainwright | Buy |
| 2020-08-13 | Reiterato | H.C. Wainwright | Buy |
| 2019-02-13 | Iniziato | B. Riley FBR | Buy |
| 2017-12-07 | Reiterato | H.C. Wainwright | Buy |
| 2017-11-28 | Reiterato | H.C. Wainwright | Buy |
| 2017-10-19 | Iniziato | ROTH Capital | Buy |
| 2017-03-30 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2016-10-03 | Downgrade | FBR & Co. | Outperform → Mkt Perform |
| 2016-09-29 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2016-09-28 | Downgrade | ROTH Capital | Buy → Sell |
| 2016-03-28 | Ripresa | H.C. Wainwright | Buy |
| 2015-09-21 | Iniziato | H.C. Wainwright | Buy |
| 2014-08-01 | Downgrade | Aegis Capital | Buy → Hold |
| 2014-07-30 | Reiterato | MLV & Co | Buy |
| 2014-07-29 | Reiterato | MLV & Co | Buy |
| 2014-04-02 | Reiterato | MLV & Co | Buy |
| 2014-02-10 | Reiterato | Aegis Capital | Buy |
| 2014-01-09 | Reiterato | Aegis Capital | Buy |
| 2013-12-03 | Iniziato | MLV & Co | Buy |
| 2013-08-19 | Reiterato | Aegis Capital | Buy |
Mostra tutto
Galectin Therapeutics Inc Borsa (GALT) Ultime notizie
What makes Galectin Therapeutics Inc. stock price move sharplyFree Capital Protection Trading Strategies - Newser
Earnings visualization tools for Galectin Therapeutics Inc.Consistent Return Setup with Exit Strategy - Newser
Top Risks to Consider Before Buying Galectin Therapeutics Inc. StockPredictive Analytics for Equity Growth Potential - Newser
What the charts say about Galectin Therapeutics Inc. todayTechnical Screener for High Growth Stocks - Newser
Signal strength of Galectin Therapeutics Inc. stock in tech scannersFree Real Trader Watchlist of Hot Stocks - Newser
What recovery options are there for Galectin Therapeutics Inc.Fundamental Analysis for Value Stock Selection - Newser
Is Galectin Therapeutics Inc. a growth stock or a value stockHigh-yield portfolio picks - Jammu Links News
Published on: 2025-08-03 20:50:30 - Newser
What are the technical indicators suggesting about Galectin Therapeutics Inc.Free Market Dynamics Reports - Jammu Links News
Is Galectin Therapeutics Inc. a good long term investmentMaximize your portfolio’s earning power - Jammu Links News
What is the risk reward ratio of investing in Galectin Therapeutics Inc. stockAchieve rapid portfolio growth with expert guidance - Jammu Links News
What are Galectin Therapeutics Inc. company’s key revenue driversNavigate market volatility with smart strategies - Jammu Links News
What are analysts’ price targets for Galectin Therapeutics Inc. in the next 12 monthsAchieve consistent high returns with low risk - Jammu Links News
How volatile is Galectin Therapeutics Inc. stock compared to the marketPowerful growth strategies - Jammu Links News
What are the latest earnings results for Galectin Therapeutics Inc.Invest smarter with actionable market insights - Jammu Links News
Combining price and volume data for Galectin Therapeutics Inc.Swing Entry Risk Mitigation with Chart Analysis - Newser
What institutional investors are buying Galectin Therapeutics Inc. stockInvest smarter with comprehensive market analysis - Jammu Links News
Is Galectin Therapeutics Inc. stock overvalued or undervaluedStrong return on assets - Jammu Links News
How strong is Galectin Therapeutics Inc. company’s balance sheetRapid wealth creation - Jammu Links News
Galectin Therapeutics Inc. Stock Analysis and ForecastCapitalize on stocks with high profit margins - Jammu Links News
Galectin Therapeutics (NASDAQ:GALT) Stock Passes Above 200-Day Moving AverageShould You Sell? - MarketBeat
How Galectin Therapeutics Inc. stock performs during market volatilityFree Trade Scanner With Buy Zone Alerts - Newser
Strategies to average down on Galectin Therapeutics Inc.Chart Risk Profile for Capital Preservation - Newser
Is it time to cut losses on Galectin Therapeutics Inc.Free Real-Time Market Sentiment Tracking Tool - Newser
Live market analysis of Galectin Therapeutics Inc.Predicted Market Direction Based on Momentum - Newser
Published on: 2025-08-01 00:21:52 - Newser
Price momentum metrics for Galectin Therapeutics Inc. explainedReal Chart Based Opportunity Identification - Newser
How does Galectin Therapeutics Inc. compare to its industry peersBreakout Stocks Watchlist That Work - jammulinksnews.com
Y Intercept Hong Kong Ltd Makes New $287,000 Investment in Galectin Therapeutics Inc. (NASDAQ:GALT) - MarketBeat
Published on: 2025-07-30 21:20:45 - metal.it
Galectin Therapeutics Inc. Hits Price Floor — Bounce IncomingReal Trader Watchlist of Hot Stocks Released - beatles.ru
Y Intercept Hong Kong Ltd Takes Position in Galectin Therapeutics Inc. (NASDAQ:GALT) - Defense World
Does Galectin Therapeutics Inc. qualify in momentum factor screeningFree Weekly Growth Stock Entry Point Alerts - Newser
Published on: 2025-07-29 18:03:19 - metal.it
Published on: 2025-07-29 17:22:41 - metal.it
Published on: 2025-07-29 06:30:28 - Newser
What catalysts could drive Galectin Therapeutics Inc. stock higher in 2025Low Risk Report For Consistent Profits - jammulinksnews.com
Galectin Therapeutics Inc Azioni (GALT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.40%
0.08%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):